The Most Successful Oncology Launches Of A Decade

 
• By Jessica Merrill

Johnson & Johnson's Zytiga and Pfizer's Sutent generated the most cumulative sales from 2006-2017, while Bristol's Opidvo and Pfizer's Ibrance were the most successful launches, according to an analysis of cancer drug launches by Leerink. 

Three Paper pinwheels isolated on white background

More from New Products

More from Scrip